LONDON (Reuters) - Turning around drugmaker AstraZeneca will be a long haul, with a strategy of revamping research and boosting acquisitions set to take up to four years to pay off, its chief executive said on ...
CHICAGO (Reuters) - Shares of U.S. hospital operators have been on a tear this year, on average posting triple the gains of the broader stock market, as investors tallied up the benefits of President Barack Obama's ...
LONDON (Reuters) - AstraZeneca and Bristol-Myers Squibb's diabetes drug Onglyza failed to reduce heart risks in a large clinical study, disappointing investors who had thought it might demonstrate an edge over ...
WASHINGTON (Reuters) - Enroll America, a nonprofit group at the center of the political fight over President Barack Obama's healthcare reform law, launched a multi-state grassroots campaign on Tuesday to help sign up ...
LONDON (Reuters) - Pharmaceutical companies need to boost the benefits of drug research by working with regulators and healthcare providers to overhaul the way medicines are approved and paid for, a thinktank backed by ...
LONDON (Reuters) - The marketing of unhealthy foods to children has proven "disastrously effective", driving obesity by using cheap social media channels to promote fat-, salt- and sugar-laden foods, the ...
CHICAGO (Reuters) - A swine virus deadly to young pigs, one never before seen in North America, is spreading rapidly across the United States and proving harder to control than previously believed.
The virus now has ...
NEW YORK (Reuters Health) - Studies that are funded by pharmaceutical companies or involve industry-backed scientists tend to be more prominent at cancer meetings than independent studies, a new report ...
NEW YORK (Reuters Health) - Large independent doctor practices that focus on primary care tend to spend less money and are more likely to meet guidelines for Americans on Medicare than smaller groups, according to a ...
NEW YORK (Reuters Health) - If a person doesn't have much success with one pain treatment, they may say the next one they try doesn't work so great either, suggests a new study from Germany.
Previous studies have found ...
